Results 211 to 220 of about 589,865 (354)

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer

Cancer Science, EarlyView.
The combination of cladribine and irradiation significantly suppressed the growth of DU145‐derived tumors compared with the DMSO plus irradiation group in the mouse model. In addition, it also elevated the percentage of γH2AX‐positive cells after irradiation.
Toshiki Oka, Koji Hatano, Shohei Katsuki, Tomohiro Kanaki, Shunsuke Inoguchi, Masaru Tani, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi, Yohei Okuda, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Yu Ishizuya, Takuji Hayashi, Yoshiyuki Yamamoto, Taigo Kato, Atsunari Kawashima, Keisuke Tamari, Bangzhong Lin, Akiyoshi Tani, Kazutake Tsujikawa, Yutaka Takahashi, Kazuhiko Ogawa, Shawn E. Lupold, Norio Nonomura   +26 more
wiley   +1 more source

The impact of tuberculosis misdiagnosis in Hodgkin lymphoma patients. [PDF]

Indian J Med Res
Singh C, Jain A, Khadwal A, Basher R, Bal A, Srinivasan R, Prakash G, Malhotra P.   +7 more
europepmc   +1 more source

Risk factors for non‐Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population‐based case‐control study

, 2010
Cindy M. Chang, Sophia Wang, Bhavana J. Davé, Smrati Jain, Mohammad A. Vasef, Dennis D. Weisenburger, Wendy Cozen, Scott Davis, Richard K. Severson, Charles F. Lynch, Nathaniel Rothman, James R. Cerhan, Patricia Hartge, Lindsay M. Morton   +13 more
openalex   +2 more sources

Non-Hodgkin lymphoma of the bladder [PDF]

, 2004
Alberto A. Antunes, Luciano Nesrallah, Miguel Srougi   +2 more
openalex   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma. [PDF]

Hematol Rep
Seidenfaden SC, Adams TG, Kamper P, Jespersen S, Pedersen MB.   +4 more
europepmc   +1 more source

Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene‐engineered advanced cell therapy products for treatment of haematological disorders

British Journal of Haematology, EarlyView.
S. Ghorashian, R. Sanderson, J. Lee, A. Black, M. A. O'Reilly, D. I. Marks, J. Snowden, D. Richardson, E. Olavarria   +8 more
wiley   +1 more source

Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell‐Derived NK Cell Therapies

Cell Proliferation, EarlyView.
Advancements in the generation of human pluripotent stem cell‐derived natural killer (PSC‐NK) cells have attracted considerable attention within the biomedical research community, offering a promising off‐the‐shelf technique for universal immune therapy.
Qianwen Chen, Jianwei Lv, Xinwei Xie, Hanlin Zhu, Zhenyu Xiao, Yaojin Peng   +5 more
wiley   +1 more source

Expression and prognostic value of FKBP51 in Hodgkin lymphoma. [PDF]

Front Immunol
Varricchio S, Romano S, Russo D, Travaglino A, Cappiello R, Cervasio M, Ilardi G, Marrone L, Pane F, Picardi M, Persico M, Vigliar E, Acanfora G, Romano MF, Mascolo M.   +14 more
europepmc   +1 more source

Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

Science Translational Medicine, 2016
C. Turtle, L. Hanafi, C. Berger, M. Hudecek, B. Pender, E. Robinson, R. Hawkins, Colette N. Chaney, S. Cherian, Xueyan Chen, L. Soma, B. Wood, Daniel H. Li, S. Heimfeld, S. Riddell, D. Maloney   +15 more
semanticscholar   +1 more source